Coulter Partners provides leadership consultancy to Life Sciences, Health and Technology innovation businesses globally. We build teams that change the world and create a better future. Over 20 years we have delivered on 1000s of assignments across the USA, Canada, UK/Europe, and APAC, advising companies and investors on how to shape and hire their boards and leadership teams. We strongly impact value and growth. Our 110 experts operate uniquely as one global team. With our track record, AI, bespoke systems and wealth of data, we fuel the ability of investors, boards and executive teams to deliver value from innovation.
The Coulter Partners team is made up of 110 experts, working in 40 countries, holding 250,000 conversations with industry leaders each year. Together we channel data and learning to the benefit of our clients. We are a diverse group of experts with backgrounds ranging from science and technology, to the arts, finance, and more. Our reward system is designed to drive one-team behaviors and we work together seamlessly to combine industry experience and global insight with our passion for progress. Our team understands and is up to date with the challenges you face and the opportunities your business can maximize. This means we can find and develop exceptional individuals to drive you forward.
Our network is carefully curated and gives us access to leaders who can guide science, technology and innovation-driven companies through all stages of growth and evolution. Our executive search is an end-to-end process, underpinned by rigorous data and analytics from our dedicated Business Intelligence function and CP:Net™, our proprietary AI-driven candidate and company database. Our Board Advisory brings over two decades’ experience in building, advising and evolving boards for private and public companies. We understand what value a board can bring and how to evaluate its suitability for the stage of the business and the 3–5-year plan. We also provide leadership advisory at every step of the way. We have a network of mentors and advisors that bring the next level of insight to your organization, to build teams that change the world.
Life sciences search specialist Coulter Partners has expanded with the addition of Christelle Kerouedan as marketing director. “We are delighted to welcome Christelle to the team and are looking forward to working with her on the next phase of development of Coulter Partners,” said CEO Bianca Coulter. Her extensive experience as a life sciences communications specialist will
Over the past few months, numerous healthcare and life sciences organizations have turned to executive search firms to find new leaders. In the era of COVID-19, the sector has been a burgeoning area for recruiters to ply their trade. Recently, life sciences search specialist Coulter Partners joined with Civetta Therapeutics in the recruitment of Christopher D. Roberts
Over the past few months, numerous healthcare organizations have turned to executive search firms to find new chief medical officers. In the era of COVID-19 this is likely to be another burgeoning area for executive search firms. Life sciences search specialist Coulter Partners recently partnered with Memo Therapeutics AG for the recruitment of George Badita as its new
Life sciences search specialist Coulter Partners recently partnered with 2N Pharma, a biotech company developing therapeutic drugs to treat neurological disorders, to secure the appointments of Alex Leech as chair of the board of directors and John Kemp as non-executive director. “We are very proud and excited to welcome Alex and John to the board,” said Preben Bruun-Nyzell,
(July 13, 2021) Coulter Partners was very pleased to partner recently with Memo Therapeutics AG, an innovator in the field of antibody discovery and development, to secure the appointment of Dr. George Badita as Chief Medical Officer. Dr. Badita is an MD, board certified in Infectious Diseases, with over 30 years of experience in life
(April 2021) Coulter Partners was very pleased to partner recently with OxSonics® Therapeutics, a world leader in the development of ultrasound-based drug delivery systems for the treatment of cancer, to secure the appointment of Dr Allison Jeynes as non-executive Chair of the Board of Directors. Dr Allison Jeynes, MD, FFPM (UK), is a trained clinician
(March 2021) Global Life Sciences executive search specialist, Coulter Partners is delighted to announce continuing growth across the company in 2021. The London team expands with new Associates, Lucy Webb and Ana Delgado, Research Analysts, Jacob Taylor and Liam Fryer, and Director, Carina McEntire. In the US, Ayn Teigman is appointed Associate in New York
(March 1, 2021) Coulter Partners was delighted to partner again recently with Optimapharm to secure the appointments of Walter Miller as Chief Finance Officer and Dr Charles Woler, M.D., Ph.D., as Non-Executive Director. Optimapharm is a contract research organization (CRO) managing clinical trials on behalf of leading biotech, pharma and medical devices companies in 27
(Aug. 27, 2020) Coulter Partners was very pleased to partner once again with Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, to secure the appointment of Jason A. Amello as Chief Financial Officer. Jason will be based in the U.S. and will support Saniona’s advancement of late-stage clinical trials with lead
Blogs
Top hires for VC & PE portfolio companies Q1-2024
D, E & I: VIEWS FROM LEADERSHIP SERIES – Lene Gerlach, Founder and Chair of Women in Life Science Denmark (WiLD), and Partner at Eir Ventures
D, E & I: VIEWS FROM LEADERSHIP SERIES – Yael Gruenbaum-Cohen, Partner at aMoon and Founder of WE@HealthTech
Top hires for VC & PE portfolio companies Q4-2023
Top global hires for large-cap, mid-cap and public companies H2-2023
Top hires for VC & PE portfolio companies Q3-2023
Top hires for VC & PE portfolio companies Q2-2023
Top global hires for large-cap, mid-cap and public companies H1-2023
Top hires for VC & PE portfolio companies Q1-2023
D, E & I: Views From Leadership Series – Charlotte Valeur, Founder of Institute Of Neurodiversity, ION
Top hires for VC & PE portfolio companies Q4-2022
Top global hires for large-cap, mid-cap and public companies H2-2022
Diversity, Equity, & Inclusion: Views From Leadership Series- Quita Highsmith, Vice President and Chief Diversity Officer at Genentech
Diversity, Equity & Inclusion: Views from Leadership-Tomoko Adachi
Diversity, Equity & Inclusion: Views from Leadership-Corinne Le Goff